Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV.
Singer S, Amdal CD, Hammerlid E, Tomaszewska IM, Castro Silva J, Mehanna H, Santos M, Inhestern J, Brannan C, Yarom N, Fullerton A, Pinto M, Arraras JI, Kiyota N, Bonomo P, Sherman AC, Baumann I, Galalae R, Fernandez Gonzalez L, Nicolatou-Galitis O, Abdel-Hafeez Z, Raber-Durlacher J, Schmalz C, Zotti P, Boehm A, Hofmeister D, Krejovic Trivic S, Loo S, Chie WC, Bjordal K, Brokstad Herlofson B, Grégoire V, Licitra L; EORTC Quality of Life and the EORTC Head and Neck Cancer Groups. Singer S, et al. Among authors: brannan c. Head Neck. 2019 Jun;41(6):1725-1737. doi: 10.1002/hed.25609. Epub 2019 Jan 12. Head Neck. 2019. PMID: 30636188 Clinical Trial.
Quality-of-Life Priorities in Patients with Thyroid Cancer: A Multinational European Organisation for Research and Treatment of Cancer Phase I Study.
Singer S, Husson O, Tomaszewska IM, Locati LD, Kiyota N, Scheidemann-Wesp U, Hofmeister D, Winterbotham M, Brannan C, Araújo C, Gamper EM, Kulis D, Rimmele H, Andry G, Licitra L. Singer S, et al. Among authors: brannan c. Thyroid. 2016 Nov;26(11):1605-1613. doi: 10.1089/thy.2015.0640. Epub 2016 Oct 12. Thyroid. 2016. PMID: 27605136
The EORTC module for quality of life in patients with thyroid cancer: phase III.
Singer S, Jordan S, Locati LD, Pinto M, Tomaszewska IM, Araújo C, Hammerlid E, Vidhubala E, Husson O, Kiyota N, Brannan C, Salem D, Gamper EM, Arraras JI, Ioannidis G, Andry G, Inhestern J, Grégoire V, Licitra L; EORTC Quality of Life Group, the EORTC Head and Neck Cancer Group, and the EORTC Endocrine Task Force. Singer S, et al. Among authors: brannan c. Endocr Relat Cancer. 2017 Apr;24(4):197-207. doi: 10.1530/ERC-16-0530. Epub 2017 Feb 21. Endocr Relat Cancer. 2017. PMID: 28223365
Quality of Life in Patients With Hypoparathyroidism After Treatment for Thyroid Cancer.
Büttner M, Locati LD, Pinto M, Araújo C, Tomaszewska IM, Kiyota N, Vidhubala E, Brannan C, Hammerlid E, Husson O, Salem D, Ioannidis G, Gamper E, Arraras JI, Andry G, Inhestern J, Theurer J, Taylor K, Singer S. Büttner M, et al. Among authors: brannan c. J Clin Endocrinol Metab. 2020 Dec 1;105(12):dgaa597. doi: 10.1210/clinem/dgaa597. J Clin Endocrinol Metab. 2020. PMID: 32918085
Development of an EORTC questionnaire measuring instrumental activities of daily living (IADL) in patients with brain tumours: phase I-III.
Oort Q, Dirven L, Sikkes SAM, Aaronson N, Boele F, Brannan C, Egeter J, Grant R, Klein M, Lips I, Narita Y, Sato H, Sztankay M, Stockhammer G, Talacchi A, Uitdehaag BMJ, Reijneveld JC, Taphoorn MJB; EORTC Quality of Life Group. Oort Q, et al. Among authors: brannan c. Qual Life Res. 2021 May;30(5):1491-1502. doi: 10.1007/s11136-020-02738-5. Epub 2021 Jan 26. Qual Life Res. 2021. PMID: 33496902 Free PMC article. Clinical Trial.
Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scale.
Singer S, Hammerlid E, Tomaszewska IM, Amdal CD, Bjordal K, Herlofson BB, Santos M, Silva JC, Mehanna H, Fullerton A, Brannan C, Gonzalez LF, Inhestern J, Pinto M, Arraras JI, Yarom N, Bonomo P, Baumann I, Galalae R, Nicolatou-Galitis O, Kiyota N, Raber-Durlacher J, Salem D, Fabian A, Boehm A, Krejovic-Trivic S, Chie WC, Taylor K, Simon C, Licitra L, Sherman AC; EORTC Quality of Life Group and the EORTC Head and Neck Cancer Group. Singer S, et al. Among authors: brannan c. Qual Life Res. 2022 Mar;31(3):841-853. doi: 10.1007/s11136-021-02939-6. Epub 2021 Jul 16. Qual Life Res. 2022. PMID: 34272632 Free PMC article.
International Validation of the EORTC QLQ-ANL27, a Field Study to Test the Anal Cancer-Specific Health-Related Quality-of-Life Questionnaire.
Sodergren SC, Johnson CD, Gilbert A, Darlington AS, Cocks K, Guren MG, Rivin Del Campo E, Brannan C, Christensen P, Chu W, Chung H, Dennis K, Desideri I, Gilbert DC, Glynne-Jones R, Jefford M, Johansson M, Johnsson A, Juul T, Kardamakis D, Lai-Kwon J, McFarlane V, Miguel IMC, Nugent K, Peters F, Riechelmann RP, Turhal NS, Wong S, Vassiliou V; European Organisation for Research and Treatment of Cancer Quality of Life Group. Sodergren SC, et al. Among authors: brannan c. Int J Radiat Oncol Biol Phys. 2023 Apr 1;115(5):1155-1164. doi: 10.1016/j.ijrobp.2022.11.002. Epub 2022 Nov 17. Int J Radiat Oncol Biol Phys. 2023. PMID: 36402360
Instrumental activities of daily living in neuro-oncology: International validation of the EORTC IADL-BN32 questionnaire.
Oort Q, Reijneveld JC, Sikkes SAM, Koekkoek JAF, Boele F, Young T, Brannan C, Chalk T, Talacchi A, Mazzotta A, Narita Y, Sato H, Miyakita Y, Shamieh O, Alrjoob W, Pace A, Petranovic D, Ploh M, Capela A, Silva J, Hjermstad MJ, Purkart TU, Seidel C, Talhi N, Pichler J, Höllmüller I, Brown L, Hand M, Klein M, Aaronson NK, Uitdehaag BMJ, Taphoorn MJB, Dirven L; EORTC Quality of Life Group and the EORTC Brain Tumor Group. Oort Q, et al. Among authors: brannan c. Eur J Cancer. 2024 Nov;212:114335. doi: 10.1016/j.ejca.2024.114335. Epub 2024 Sep 21. Eur J Cancer. 2024. PMID: 39332215 Free article.
Do neurocognitive impairments explain the differences between brain tumor patients and their proxies when assessing the patient's IADL?
Oort Q, Dirven L, Sikkes SAM, Aaronson N, Boele F, Brannan C, Egeter J, Grant R, Klein M, Lips IM, Narita Y, Sato H, Sztankay M, Stockhammer G, Talacchi A, Uitdehaag BMJ, Reijneveld JC, Taphoorn MJB. Oort Q, et al. Among authors: brannan c. Neurooncol Pract. 2022 Feb 26;9(4):271-283. doi: 10.1093/nop/npac016. eCollection 2022 Aug. Neurooncol Pract. 2022. PMID: 35855454 Free PMC article.
71 results